We are currently hiring a HEOR Lead Hyperkalemia for our dynamic Market Access team. In this role you will be a key player in leading the development of HEOR evidence that supports business strategies and Market Access efforts across all our assets with particular focus on our Hyperkalemia drugs. In addition you will lead the develop and execute of evidence leveraging Vifor’s disease area expertise, supporting Market Access strategies, engaging decision-makers, influencers, and stakeholders, in order to have the appropriate data (clinical, QoL,economic, societal) to support patient access.
Your responsibilities will include:
Works directly with other Market Access teams to meet the needs of patients, payers and policy makers
Manages the coordination and collaboration of global, regional (if applicable) and country health economic teams to understand country-specific HEOR needs and opportunities and the respective activities
Oversees that HEOR advises Medical Affairs and Clinical teams in the design of health outcomes/interventional and observational trials with health economic and Patient Reported Outcomes (PRO) endpoints in alignment with therapy and product value propositions for optimal impact on access decision-makers, influencers, and stakeholders
Leads the development and coordination of company wide health economic tools that are part of the “core value tools” including BIM, CEM, GVD (AMCP & EUNetHTA format)
Establishes proactive listening systems to monitor the implications of systemic changes in evidence requirements, determine implications, and proposes necessary changes to ensure positive impact of Vifor’s evidence strategies across TAs
Performs all Vifor business in accordance with appropriate regulations and industry guidelines
Ensures HEOR input to the PRB & PRC
The role is part of the global access leadership team. It reports to the global head of Pricing & Access.
We would like to welcome the following experience and skills for the role:
Undergraduate degree in Health or Social Sciences
PhD, MSc, or equivalent in Health Economics, Public Health, Mathematics or related field
10 years of experience in health economics and/or outcomes research in pharmaceutical industry
Experience in one or more key markets (geographic or disease area markets) would be ideal (including top 5 European and/or the US, as well as ESRD and/or CHF)
Language requirement: English plus one other language ideally French, German, or Spanish
Vifor Pharma Group is a global pharmaceuticals company. It holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care). Vifor Pharma Group is listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).